Short-term morbidity from CT-planned transperineal I-125 prostate implants.
暂无分享,去创建一个
J Roy | Z Fuks | J. Roy | K. Wallner | Z. Fuks | K Wallner | V. Arterbery | V E Arterbery
[1] P. Walsh,et al. Radical retropubic prostatectomy. Improved anastomosis and urinary continence. , 1990, The Urologic clinics of North America.
[2] J. Lattimer,et al. Complications and regression of primary tumor size with radiotherapy in prostatic cancer. , 1972, The Journal of urology.
[3] J Roy,et al. An improved method for computerized tomography-planned transperineal 125iodine prostate implants. , 1991, The Journal of urology.
[4] C. Perez,et al. Irradiation of carcinoma of the prostate localized to the pelvis: analysis of tumor response and prognosis. , 1980, International journal of radiation oncology, biology, physics.
[5] C. Perez,et al. Complications of definitive radiotherapy for carcinoma of the prostate. , 1980, International journal of radiation oncology, biology, physics.
[6] R. B. Smith,et al. Risk of urinary incontinence following radical prostatectomy. , 1983, The Journal of urology.
[7] A. Porter,et al. Prostate‐specific antigen: Monitoring the response of carcinoma of the prostate to radiotherapy with a new tumor marker , 1990, Cancer.
[8] W. Whitmore,et al. Complications of 125iodine implantation and pelvic lymphadenectomy in the treatment of prostatic cancer. , 1979, The Journal of urology.
[9] L. Brady,et al. 125Iodine implantation after lymphadenectomy in early carcinoma of the prostate. , 1986, International journal of radiation oncology, biology, physics.
[10] G. Edmundson,et al. Pelvic lymphadenectomy and transperineal interstitial implantation of IR 192 combined with external beam radiotherapy for bulky stage C prostatic carcinoma. , 1989, International journal of radiation oncology, biology, physics.
[11] R. Peschel,et al. Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancer. , 1988, International journal of radiation oncology, biology, physics.
[12] E. Vaughan,et al. Medical management of benign prostatic hyperplasia. , 1990, Urology.
[13] H. Lepor. Role of long-acting selective alpha-1 blockers in the treatment of benign prostatic hyperplasia. , 1990, The Urologic clinics of North America.
[14] C. Perez,et al. Tumor control in definitive irradiation of localized carcinoma of the prostate. , 1986, International journal of radiation oncology, biology, physics.
[15] W. Shipley,et al. Preoperative irradiation, lymphadenectomy, and 125iodine implantation for patients with localized carcinoma of the prostate. , 1986, International journal of radiation oncology, biology, physics.
[16] W. Catalona,et al. Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. , 1990, The Journal of urology.
[17] D. Kuban,et al. I–125 interstitial implantation for prostate cancer. What have we learned 10 years later? , 1989, Cancer.
[18] B. S. Barringer. RADIUM IN THE TREATMENT OF CARCINOMA OF THE BLADDER AND PROSTATE: REVIEW OF ONE YEAR'S WORK , 1917 .
[19] Transperineal seed-implantation guided by biplanar transrectal ultrasound. , 1990, Urology.